<SEC-DOCUMENT>0001415889-25-013195-index.html : 20250515 <SEC-HEADER>0001415889-25-013195.hdr.sgml : 20250515 <ACCEPTANCE-DATETIME>20250515165502 ACCESSION NUMBER: 0001415889-25-013195 CONFORMED SUBMISSION TYPE: SCHEDULE 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20250515 DATE AS OF CHANGE: 20250515 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Dianthus Therapeutics, Inc. /DE/ CENTRAL INDEX KEY: 0001690585 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-90538 FILM NUMBER: 25954972 BUSINESS ADDRESS: STREET 1: 7 TIMES SQUARE STREET 2: 43RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 929-999-4055 MAIL ADDRESS: STREET 1: 7 TIMES SQUARE STREET 2: 43RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: Magenta Therapeutics, Inc. DATE OF NAME CHANGE: 20161121 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: RA CAPITAL MANAGEMENT, L.P. CENTRAL INDEX KEY: 0001346824 ORGANIZATION NAME: EIN: 830406777 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G/A BUSINESS ADDRESS: STREET 1: 200 BERKELEY STREET, 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-778-2500 MAIL ADDRESS: STREET 1: 200 BERKELEY STREET, 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: RA CAPITAL MANAGEMENT, LLC DATE OF NAME CHANGE: 20051213 </SEC-HEADER> <DOCUMENT> <TYPE>SCHEDULE 13G/A <SEQUENCE>1 <FILENAME>primary_doc.xml <TEXT> Document 1 - file: primary_doc.html
Document 1 - RAW XML: primary_doc.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>ex-99-05152025_080502.htm <DESCRIPTION>JOINT FILING AGREEMENT <TEXT> Document 2 - file: ex-99-05152025_080502.htm
</DOCUMENT> </SEC-DOCUMENT>